Price
No data yet.
Social Signal Score
Revenue
$53.20M+637.83%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Orlando Oliveira
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 78
- Beta
- -0.28
- Country
- CH
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- -5.63
Financials
Revenue
$53.20M+637.8%Net Income
$-10.41MEBITDA
$480.2KFree Cash Flow
$-14.22MEPS (diluted)
$-0.78Shares Outstanding (diluted)
13.39M+2039.0%Operating Expenses
$25.31MCash & Debt
$22.45MReturn of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $77.22M | $-49.26M | $-3.78 |
| 2024 | $39.12M | $-41.97M | $-3.69 |
| 2023 | $103.41M | $54.78M | $5.18 |
| 2022 | $7.47M | $-71.08M | $-11.67 |
| 2021 | $-1.59M | $-55.53M | $-16.25 |
| 2020 | $15.01M | $-67.66M | $-50.81 |
| 2019 | $75.38M | $-18.97M | $-17.26 |
| 2018 | $31.66M | $-54.19M | $-78.63 |
| 2017 | $22.94M | $-51.53M | $-82.19 |
| 2016 | $19.03M | $-35.41M | $-56.50 |
| 2015 | $4.32M | $5.95M | $11.10 |
| 2014 | $2.59M | $-7.53M | $-16.02 |
| 2013 | $1.32M | $-5.75M | $-15.52 |
| 2012 | $3.54M | $-31.45M | $-85.53 |
Valuation
SPHDFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
90Social Signal Score
Mentions (1)
- Newsproactiveinvestors.co.uk·1d ago·Negative
Santhera nears cash break-even as AGAMREE gains traction, Edison says Santhera Pharmaceuticals (SIX:SANN, OTC:SPHDF, FRA:S3F0), the Swiss rare-disease drugmaker, is closing in on a financial turning point, according to research house Edison. In a QuickView note published on Tuesday, analysts Jyoti Prakash and Arron Aatkar said the company was on track to reach cash flow break-even in the third quarter, completing its shift into a self-funded business.
View source ↗
Earnings
Mon, Sep 21(in 5 weeks)
Typical surprise -409.5% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Sep 15$-3.83 vs $-0.75miss
Estimates and results for SPHDF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.